Keyphrases
Cisplatin-based Chemotherapy
100%
Subgroup Analysis
100%
Early-stage Lung Cancer
100%
Adjuvant Chemotherapy
100%
Prognostic Signature
100%
Predictive Gene Signature
100%
Chemotherapy Treatment
60%
Survival Benefit
40%
Risk Category
40%
Survival Time
20%
Clinical Trials
20%
Gene Expression Profiling
20%
Treatment Group
20%
National Cancer Institute
20%
Patient Survival
20%
Survival Rate
20%
Simulation Study
20%
Epigenetic Biomarkers
20%
Decision Algorithm
20%
Gene number
20%
Treatment-related
20%
Chemotherapy Alone
20%
Surgery Alone
20%
Success Probability
20%
Chemotherapy Toxicity
20%
Cox Proportional Hazards Regression Model
20%
New Patients
20%
Patient Prognosis
20%
Stage I Lung Cancer
20%
Stage IB
20%
Statistical Decision-making
20%
LASSO Algorithm
20%
Random Forest Regression
20%
Inherent Toxicity
20%
Mathematics
Simulation Study
100%
Treatment Group
100%
Cancer Patient
100%
Proportional Hazards Model
100%
Survival Time
100%
Survival Rate
100%
Nursing and Health Professions
Non Small Cell Lung Cancer
100%
Cisplatin
100%
Adjuvant Chemotherapy
100%
Group Therapy
20%
National Health Organization
20%
Physician
20%
Survival Rate
20%
Proportional Hazards Model
20%
Biological Marker
20%
Oncologist
20%
Survival Time
20%
Random Forest
20%
Gene Expression Profiling
20%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Chemotherapy
100%
Cisplatin
62%
Malignant Neoplasm
12%
Clinical Trial
12%
Biological Marker
12%
Survival Rate
12%
Survival Time
12%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
Gene Signature
100%
Gene Expression Profiling
20%
Clinical Trial
20%
Survival Rate
20%
Survival Time
20%
Random Forest
20%
Decision Making
20%